Skip to main content

Detection of African Swine Fever Virus Antibodies in Serum and Oral Fluid Specimens Using a Recombinant Protein 30 (p30) Dual Matrix Indirect ELISA.

In the absence of an effective vaccine (s), the control of African swine fever is caused by African swine fever virus (ASFV) should be based on early, efficient, cost-effective detection and control and elimination of strict strategy. To this end, we developed an indirect ELISA was able to detect antibodies ASFV either serum or oral fluid specimens. 

Recombinant proteins used in the ELISA selected by comparing the serum antibody responses beginning of ASFV-infected pigs (NHV-P68 isolates) Fruit fly Recombinant Proteins for the three major recombinant polypeptide (p30, P54, p72) using multiplex fluorescent microbead-based immunoassay (FMIA). Not dangerous serum (non-infectious) antibody-positive to be used as a positive control plates and for the calculation of sample-to-positive (S: P) ratio was produced by inoculation of pigs with replicon particle vaccines (RP) revealed that ASFV p30 gene.

 Optimized ELISA detected anti-p30 antibodies in serum and / or oral fluid samples from pigs inoculated with ASFV under experimental conditions ranging from 8 to 12 days post inoculation. Tests in serum (n = 200) and oral fluid (n = 200) samples the field of free ASFV population indicates that the test is highly specific diagnostic. 

Comfort and utility of diagnostic sampling oral fluid combined with the flexibility to test either serum or oral fluid on the same platform shows that this test will be very useful in the condition that the OIE recommends monitoring antibody ASFV, namely, in the area of ​​ASFV-endemic and for detecting infection by ASFV low virulence isolates.


Recombinant Protein p30 for serological diagnosis of African Swine Fever by Immunobloiting Assay.


This article is devoted to the development and evaluation of immunoblotting test systems for the serological diagnosis of African swine fever (ASF), based on highly purified recombinant p30 of ASF virus (ASFV) strain 01/08 Stavropol (Stavropol, 2008), the representative of ASFV currently circulating in Russian Federation. 

The main project phases are as follows: (i) the cloning of the central hydrophilic region CP204L ASFV gene (p30) into a prokaryotic vector; (Ii) the expression of p30 and chromatographic purification of recombinant products with thioredoxin and poly-histidine site (p30e1_TrxA_6xHis); (Iii) the development of test systems immunoblotting (Rec p30-IB) using highly purified recombinant p30; and (iv) the
Detection of African Swine Fever Virus Antibodies in Serum and Oral Fluid Specimens Using a Recombinant Protein 30 (p30) Dual Matrix Indirect ELISA.
evaluation of p30-IB Rec
using General Recombinant Proteins  sera and organ samples from domestic pigs and wild boar experimentally or naturally infected by ASFV. 

Rec Testing p30-IB show diagnostic specificity and sensitivity of the test to be 98.75% and 100.00%, respectively. high sensitivity of Rec p30-IB allowed the detection of antibodies ASFV specific in samples of organs of the immune system and sera of blood, collected from domestic pigs and wild boar, from 6 to 8 days post-infection, regardless of virus virulence, seroimmunotype and origin geographic sample

Comments

Popular posts from this blog

Development of Recombinant Protein-Based Vaccine Against Classical Swine Fever Virus in Pigs Using Transgenic Nicotiana benthamiana.

Classical swine fever virus (CSFV) is highly contagious and fatal to infected pigs. Vaccines against CSFV have been developed from inactivated or modified live virus. The vaccine is effective for immunization of animals, but they are associated with E.coli Recombinant Proteins  problems such as accidental spread of animal viruses in the field, and with trade barriers following vaccination. Here, we report the generation of transgenic Nicotiana benthamiana plants for large-scale, cost-effective production E2 fusion proteins for use as a recombinant vaccine against CSFV in pigs. Transgenic N. benthamiana plants save an intergenic, single-copy insertion of a chimeric gene encoding a fusion protein E2 has a high level of expression of the transgene. For large-scale production of the fusion protein E2 leaf tissue, we developed protein purification protocol consisting of a cellulose-binding domain (CBD) -cellulose affinity based purification and size-exclusion gel filtration chromatography

Evaluation of the Efficacy of a Recombinant Adenovirus Expressing the Spike Protein of Porcine Epidemic Diarrhea Virus in Pigs.

In recent years, many studies have shown that a live recombinant adenovirus vector-based vaccine is a promising new vaccine candidates against viral infection. Therefore, in this study, a new type of recombinant adenovirus expressing spike (S) protein Cavia Recombinant Proteins pig epidemic diarrhea virus (PEDV), RAD-PEDV-S, produced, and characteristics are determined.  Then, its efficacy as a vaccine candidate was evaluated in pigs 4-week-old. The results showed that protein S can also be expressed at high levels in the RAD-PEDV-S-infected cells and that the viral titers can reach 1 011 PFU / mL. Furthermore, the results of animal experiments show that the RAD-PEDV-S pose a significant response specific PEDV humoral immunity after vaccination (P <0.05). In addition, RAD-PEDV-S provides partial protection for swine against PEDV extremely lethal challenge.  The results presented in this study demonstrate that the adenovirus vector can be used as a vaccine vector for vaccine devel

Delivery of a matrix metalloproteinase-responsive hydrogel releasing TIMP-3 after myocardial infarction: effects on left ventricular remodeling.

Despite the improvements in time and approach to early reperfusion in acute coronary syndromes occur, culminating myocardial injury in myocardial infarction (MI) remains a common event. Despite the multifactorial process, the imbalance between the induction of proteolytic pathways, such as matrix metalloproteinases ( MMPs) and endogenous tissu e inhibitors Ovine Recombinant Proteins  of metalloproteinases (TIMPs), have been shown to contribute to this process.  In this study, a full-length recombinant TIMP-3 protein (rTIMP-3) are packed in a specially formulated hyaluronic acid (HA) based hydrogel containing MMP-cleavable peptide cross-links, which affects the level of rTIMP- 3 release of the HA gel , Effects of local delivery of MMP-sensitive HA this gel (HAMMPS) alone and contains rTIMP-3 (HAMMPS / rTIMP-3) examined in terms of the natural history of post-MI remodeling.  Pigs were randomized to one of the following three distinct groups: MI and injection of saline (MI / saline group,